We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Leukocyte Ig-like receptor A3 facilitates inflammation, migration and invasion of synovial tissue-derived fibroblasts via ERK/JNK activation.
- Authors
Liu, Mengru; Tang, Yundi; Du, Yan; Zhang, Jing; Hu, Fanlei; Zou, Yundong; Li, Yingni; Zhu, Lei; He, Jing; Guo, Jianping; Li, Zhanguo
- Abstract
Objective Leukocyte Ig-like receptor A3 (LILRA3) is a soluble receptor belongs to the immunoglobulin superfamily. Our previous studies demonstrated that LILRA3 is a common genetic risk for multiple autoimmune diseases, including RA. Functional LILRA3 conferred increased risk of joint destruction in patients with early RA. We undertook this study to further investigate the pathological role of LILRA3 in joint inflammation of RA. Methods Soluble LILRA3 was measured by ELISA. LILRA3 plasmids were transfected into human fibroblast-like synoviocytes (FLSs) using electroporation. Activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) was determined by western blots. Cytokine transcripts were quantified by real-time PCR. Migratory and invasive capacities of FLSs were evaluated using transwell migration and Matrigel invasion assays. FLS apoptosis was analysed using flow cytometry. Colocalization of LILRA3, LILRB1 and HLA-G in RA-FLSs was visualized by immunofluorescence staining. Results Soluble LILRA3 was specifically expressed in synovial fluid and serum LILRA3 was significantly increased and positively correlated with disease activity/severity in RA patients. LILRA3 induced an increased expression of IL-6, IL-8 and MMP3 in RA-FLSs. In vitro LILRA3 stimulation or overexpression promoted RA-FLS migration and invasion, and enhanced phosphorylation of ERK/JNK. Inhibition of ERK/JNK resulted in suppression of IL-6/IL-8 expression in LILRA3-stimulated RA-FLSs. LILRA3 was co-localized with its homologue LILRB1 and shared ligand HLA-G in RA-FLSs. Conclusion The present study provides the first evidence that soluble LILRA3 is a novel proinflammatory mediator involved in synovial inflammation by promoting RA-FLS activation, migration and invasion, probably through the ERK/JNK signalling pathways.
- Subjects
FLOW cytometry; SYNOVIAL membranes; FIBROBLASTS; INFLAMMATION; WESTERN immunoblotting; CELL receptors; APOPTOSIS; CELLULAR signal transduction; SEVERITY of illness index; TRANSFERASES; ENZYME-linked immunosorbent assay; ELECTROPORATION; FLUORESCENT antibody technique; RESEARCH funding; BIOLOGICAL assay
- Publication
Rheumatology, 2024, Vol 63, Issue 3, p846
- ISSN
1462-0324
- Publication type
Article
- DOI
10.1093/rheumatology/kead359